News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,928 Results
Type
Article (7903)
Company Profile (9)
Press Release (164016)
Section
Business (57686)
Career Advice (522)
Deals (10296)
Drug Delivery (22)
Drug Development (24397)
Employer Resources (31)
FDA (4205)
Job Trends (4375)
News (94508)
Policy (7352)
Tag
Academia (467)
Alliances (7045)
Alzheimer's disease (375)
Approvals (4216)
Artificial intelligence (42)
Bankruptcy (104)
Best Places to Work (3946)
Breast cancer (110)
Cancer (749)
Cardiovascular disease (47)
Career advice (426)
CAR-T (40)
Cell therapy (124)
Clinical research (20930)
Collaboration (178)
Compensation (99)
COVID-19 (675)
Data (802)
Diabetes (70)
Diagnostics (1688)
Earnings (43825)
Events (27291)
Executive appointments (131)
FDA (4484)
Funding (186)
Gene therapy (78)
GLP-1 (243)
Government (1132)
Healthcare (5186)
Infectious disease (721)
Inflammatory bowel disease (50)
Interviews (92)
IPO (6573)
Job creations (710)
Job search strategy (380)
Layoffs (116)
Legal (1368)
Lung cancer (113)
Lymphoma (70)
Manufacturing (64)
Medical device (3541)
Medtech (3541)
Mergers & acquisitions (3809)
Metabolic disorders (207)
Neuroscience (502)
NextGen Class of 2024 (1405)
Non-profit (1035)
Northern California (785)
Obesity (122)
Opinion (42)
Parkinson's disease (38)
People (5532)
Phase I (5454)
Phase II (8818)
Phase III (8195)
Pipeline (383)
Postmarket research (952)
Preclinical (1754)
Radiopharmaceuticals (77)
Rare diseases (88)
Real estate (892)
Regulatory (5329)
Research institute (432)
Resumes & cover letters (88)
Southern California (601)
Startups (581)
United States (6176)
Vaccines (188)
Weight loss (84)
Date
Last 7 days (284)
Last 30 days (1215)
Last 365 days (13574)
2024 (13535)
2023 (12586)
2022 (16375)
2021 (16028)
2020 (14214)
2019 (12463)
2018 (9249)
2017 (8431)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
Location
Africa (192)
Asia (10435)
Australia (1739)
California (1670)
Canada (525)
China (136)
Colorado (75)
Connecticut (105)
Delaware (65)
Europe (24928)
Florida (193)
Georgia (58)
Illinois (142)
Indiana (89)
Japan (47)
Maryland (178)
Massachusetts (1279)
Michigan (44)
Minnesota (87)
New Jersey (493)
New York (480)
North Carolina (231)
Northern California (785)
Ohio (51)
Pennsylvania (351)
South America (285)
Southern California (601)
Texas (269)
Utah (51)
Virginia (41)
Washington State (167)
171,928 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
Elicio Therapeutics, Inc. announced new preliminary data from the ongoing AMPLIFY-7P Phase 1a study of its off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P.
June 27, 2024
·
6 min read
Press Releases
7 Most Promising Drugs in Parkinson’s Disease Treatment Pipeline
December 10, 2024
·
1 min read
Press Releases
AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
December 1, 2024
·
8 min read
Lone Star Bio
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
7 Hills Pharma Inc., a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, was awarded $4.7 million from the Cancer Prevention and Research Institute of Texas to support its cell/gene therapy development program.
June 3, 2024
·
5 min read
Press Releases
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
November 26, 2024
·
1 min read
Press Releases
NextPoint Therapeutics Announces Upcoming Poster Presentation on a B7-H7 Directed T Cell Engager Therapy at SITC2024
November 7, 2024
·
3 min read
Press Releases
vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
December 3, 2024
·
2 min read
Press Releases
Apnimed to Participate in the 7th Annual Evercore HealthCONx Conference
November 21, 2024
·
1 min read
Press Releases
ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial
December 9, 2024
·
2 min read
Press Releases
Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference
November 28, 2024
·
1 min read
1 of 17,193
Next
